Circulating and dietary advanced glycation end products and obesity in an adult population: A paradox of their detrimental effects in obesity

BACKGROUND: The detrimental role of advanced glycation end products (AGEs) against cardio-metabolic health has been revealed in several previous reports. However, the results of studies regarding the association between AGEs and obesity measurements are inconsistent. In the current meta-analysis, we aimed to quantitatively summarize the results of studies that evaluated the association between circulating and dietary AGEs with obesity measurements among the adult population. METHODS: A systematic search from PubMed, Embase, and Scopus electronic databases until 30 October 2022 retrieved a total of 21,429 observational studies. After duplicate removal, title/abstract screening, and full-text reading by two independent researchers, a final number of 18 manuscripts remained to be included in the meta-analysis. RESULTS: Those in the highest category of circulating AGEs had ~1.5 kg/m(2) reduced BMI compared with those in the lowest AGEs category [weighted mean difference (WMD): −1.485; CI: −2.459, −0.511; p = 0.003], while a nonsignificant increase in BMI was observed in the highest versus lowest category of dietary AGEs (WMD: 0.864, CI: −0.365, 2.094; p = 0.186). Also, lower amounts of circulating AGEs in individuals with obesity versus individuals without obesity were observed (WMD: −57.220, CI: −84.290, −30.149; p < 0.001). AGE type can be considered as a possible source of heterogeneity. CONCLUSION: In the current meta-analysis, we observed an inverse association between circulating AGEs and body mass index among adults. Due to low study numbers, further studies are warranted to better elucidate these results.